← FDA Drug Approvals (Drugs@FDA)
EMROSI
NDA · New Drug Application · Sponsor: JOURNEY · Approved 2024-11-01
Drug application
- FDA Application #
NDA219015- Application type
- New Drug Application
- Brand name
- EMROSI
- Generic name
- MINOCYCLINE HYDROCHLORIDE EXTENDED-RELEASE
- Active ingredients
- MINOCYCLINE HYDROCHLORIDE
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- JOURNEY
- Manufacturer
- Journey Medical Corporation
- First approval
- 2024-11-01
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown